TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+1.29%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$330M
AUM Growth
+$330M
(+69%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
40.67%
Top 10 Holdings %
Top 10 Hldgs %
74.15%
Holding
31
New
9
Increased
11
Reduced
2
Closed
8
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$29.2M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$20.5M |
| 3 |
Ascendis Pharma
ASND
|
$19.9M |
| 4 |
UnitedHealth
UNH
|
$18.9M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$18.1M |
Top Sells
| 1 |
Cigna
CI
|
$24.3M |
| 2 |
McKesson
MCK
|
$18.1M |
| 3 |
Gilead Sciences
GILD
|
$10M |
| 4 |
Illumina
ILMN
|
$9.58M |
| 5 |
Insmed
INSM
|
$7.77M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
McKesson
MCK
$85.9B
| – | – |
-26,944
| Closed | -$18.1M |
|
|
27
Insmed
INSM
$30.3B
| – | – |
-101,859
| Closed | -$7.77M |
|
|
28
Illumina
ILMN
$15.2B
| – | – |
-120,729
| Closed | -$9.58M |
|
|
29
Gilead Sciences
GILD
$140B
| – | – |
-89,453
| Closed | -$10M |
|
|
30
Cigna
CI
$80.2B
| – | – |
-73,905
| Closed | -$24.3M |
|
|
BPMC
31
DELISTED
Blueprint Medicines
BPMC
| – | – |
-50,000
| Closed | -$4.43M |
|